InSite Vision Is Focused On Developing Innovative Ophthalmic Products Using Their Core DuraSite® Technology To Enable Topical Delivery And Sustained Release Of Drug Molecules For Reduced Frequency Of Treatment And Improved Efficacy |
|
|
InSite Vision Incorporated (ISV-AMEX) |
|
|
“Our focus at the present has been on ocular infection. There are multiple types of ocular infection that occur both in the younger as well as the older population. Unfortunately, prior to our product AzaSite, medicaments that are presently available have a short residence time in the eye, and so must be administered far too frequently – sometimes as much as eight to ten times a day to provide good efficacy...” - S. Kumar Chandrasekaran, Ph.D. (ISV) (Interview published August 22, 2008) |
The Most Powerful Name In Corporate News and Information. |
|
CURRENT ISSUE | COVER ARCHIVES | INDEX | CONTACT | FINANCIALS | MARKETING SERVICES | HOME PAGE |
|
Become a member and access our interview with: S. Kumar Chandrasekaran, Ph.D., CEO (ISV)
|
|
